GE Healthcare invites the world to show their support for more than 10 million people living with Parkinson's disease. World Parkinson's Day is celebrated annually on this day, April 11th, the birthday of Dr. James Parkinson, for whom the disease is named.
The day is dedicated to advocating for people with Parkinson's disease, increasing awareness of the debilitating neurodegenerative disease, and driving new research and treatment initiatives. GE Healthcare is encouraging those who want to learn more about the differences in diagnosis between Parkinsonian syndromes and essential tremor movement disorders, the benefits of movement and resources to support caregivers and patients to visit its website www.move2answers.com.
Parkinson's disease, the most common Parkinsonian movement disorder and second most common neurodegenerative disorder after Alzheimer’s disease, is a chronic neurological disease caused by the loss of dopamine in the brain. There is no cure. Symptoms include: resting tremor, slowness of movement, stiffness or rigidity of muscles, difficulty with balance and walking, changes in voice volume and speech, and difficulty with fine movements. Non-motor symptoms include depression, loss of sense of smell, sleep disturbances and cognitive changes. The average age of onset is 60, but it can affect people as young as 20, 30 or 40.
When symptoms of the disorder appear, they may be mistaken for normal signs of aging or a condition such as arthritis. If you start to notice symptoms such as shaking, balance problems, stiffness, or slowed movement in yourself or a loved one, speak to your doctor. He or she will look at your symptoms and your medical history and decide what testing would be helpful.
Diagnosis is Key
With the correct diagnosis, the most appropriate treatment can begin immediately. This can lead to the best chances for a good outcome while avoiding unnecessary side effects from inappropriate treatments.
GE Healthcare’s Commitment
GE Healthcare takes a comprehensive approach to understanding a variety of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, post-traumatic stress disorder, concussion, traumatic brain injury and Multiple Sclerosis through its ongoing research to uncover the causes, risks, and physical effects of these conditions. By collaborating with the pharmaceutical industry to assist in their development of the next generation of therapies to treat these disorders and working with potential partners in the industry, GE Healthcare can provide imaging support for clinical trials of therapeutic agents.